MARKET

NSTG

NSTG

NanoString Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

55.75
-2.52
-4.32%
Closed 16:14 05/11 EDT
OPEN
55.13
PREV CLOSE
58.27
HIGH
58.28
LOW
53.32
VOLUME
1.53M
TURNOVER
--
52 WEEK HIGH
86.42
52 WEEK LOW
27.46
MARKET CAP
2.52B
P/E (TTM)
-19.5539
1D
5D
1M
3M
1Y
5Y
Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat
Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics company reported strong earnings on Tuesday.
Benzinga · 3h ago
--Baird Adjusts Price Target on NanoString Technologies to $74 From $78, Keeps Outperform Rating
MT Newswires · 20h ago
--Morgan Stanley Adjusts Price Target on NanoString Technologies to $65 From $70, Maintains Equal-Weight Rating
MT Newswires · 21h ago
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ: AAPL) on Monday, just days after halving its stake in the maker of iPhones and iPads, and snapped up shares of cryptocurrency exchange Coinbase Global Inc (NASDAQ:
Benzinga · 1d ago
NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates
Zacks.com · 1d ago
10-Q: NANOSTRING TECHNOLOGIES INC
(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Special Note Regarding...
Edgar Online - (EDG = 10Q, 10K) · 1d ago
BRIEF-Nanostring Technologies Posts Quarterly Loss Per Share Of $0.62
reuters.com · 1d ago
NanoString Technologies: Q1 Earnings Insights
Shares of NanoString Technologies (NASDAQ:NSTG) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 7.46% year over year to ($0.62), which missed the estimate of ($0.54).
Benzinga · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NSTG. Analyze the recent business situations of NanoString Tech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NSTG stock price target is 77.20 with a high estimate of 85.00 and a low estimate of 70.00.
EPS
Institutional Holdings
Institutions: 259
Institutional Holdings: 63.42M
% Owned: 140.28%
Shares Outstanding: 45.21M
TypeInstitutionsShares
Increased
80
9.35M
New
55
2.13M
Decreased
36
4.91M
Sold Out
13
304.98K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.71%
Healthcare Equipment & Supplies
-0.50%
Key Executives
Chairman/Independent Director
William Young
President/Chief Executive Officer/Director
R. Bradley Gray
Chief Financial Officer
K. Thomas Bailey
Senior Vice President/Director of Sales/Director of Marketing
J. Chad Brown
Senior Vice President/Director of Sales/Director of Marketing
John Brown
Senior Vice President
Joseph Beechem
Senior Vice President
David Ghesquiere
Director
Janet George
Director
Dana Rollison
Independent Director
Elisha Finney
Independent Director
Robert Hershberg
Independent Director
Don Kania
Independent Director
Kirk Malloy
Independent Director
Gregory Norden
Independent Director
Charles Waite
No Data
About NSTG
NanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company's nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Company markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use.

Webull offers kinds of NanoString Technologies Inc stock information, including NASDAQ:NSTG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSTG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NSTG stock methods without spending real money on the virtual paper trading platform.